Publications by authors named "Lawrence D Sher"

Claim this Profile
L
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).
Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C Oriel, Lawrence D Sher

J Allergy Clin Immunol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.
Mark Boguniewicz, Lawrence D Sher, Amy S Paller, Peter D Arkwright, Shigemi Yoshihara

Adv Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds.
Lawrence D Sher, Justice K Boakye-Appiah, Sungeen Hill, Emily Wasserman, Xia Xu

J Pediatric Infect Dis Soc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis.
Barbara Rewerska, Lawrence D Sher, Sady Alpizar, Sylvia Pauser, Grazyna Pulka

J Allergy Clin Immunol Glob· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.
Jonathan Corren, Nicola A Hanania, William W Busse, Lawrence D Sher, Arman Altincatal

Clin Exp Allergy· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab long-term efficacy in patients with non-OCS-dependent asthma with and without evidence of allergic asthma.
Lawrence D Sher, Jonathan Corren, Ian D Pavord, Nadia Daizadeh, Arman Altincatal

J Asthma· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
Guy de Bruyn, Joyce Wang, Annie Purvis, Martin Sanchez Ruiz, Haritha Adhikarla, Lawrence D Sher

EClinicalMedicine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma.
Lawrence D Sher, Giovanni Passalacqua, Camille Taillé, Lauren Cohn, Nadia Daizadeh

Ann Allergy Asthma Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
Flor M Muñoz, Lawrence D Sher, Charu Sabharwal, Alejandra Gurtman, Xia Xu

N Engl J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C Oriel, Lawrence D Sher

J Allergy Clin Immunol Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial.
Lawrence D Sher, Michael E Wechsler, Klaus F Rabe, Jorge F Maspero, Nadia Daizadeh

Chest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Saranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, Agustin Bueso, Anne-Laure Chabanon, Lawrence D Sher

Lancet Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
Leonard B Bacharier, Jorge F Maspero, Constance H Katelaris, Alessandro G Fiocchi, Remi Gagnon, Lawrence D Sher

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
Paul A Goepfert, Bo Fu, Anne-Laure Chabanon, Matthew I Bonaparte, Matthew G Davis, Lawrence D Sher

Lancet Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function.
Ian D Pavord, Salman Siddiqui, Alberto Papi, Jonathan Corren, Lawrence D Sher

J Asthma Allergy· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
Lawrence D Sher, Gloria Yiu, Anat Sakov, Siyu Liu, Cynthia F Caracta

Allergy Asthma Proc· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Academy of Allergy, Asthma & Immunology membership experience with allergen immunotherapy safety in patients with specific medical conditions.
Désirée E S Larenas-Linnemann, David W Hauswirth, Christopher W Calabria, Lawrence D Sher, Matthew A Rank

Allergy Asthma Proc· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin.
Lawrence D Sher, Michael D Poole, Kristen Von Seggern, Matthew A Wikler, Susan C Nicholson

Otolaryngol Head Neck Surg· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.
Lawrence D Sher, Michael A McAdoo, Robert B Bettis, Mark A Turner, Nicole F Li

Clin Ther· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis